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A
7-YEAR-OLD BOY WAS OBSERVED TO HAVE A
short PR interval on monitoring during
anaesthesia for tonsillectomy. Subsequent
twelve-lead electrocardiograms (Fig 1) showed
Wolff-Parkinson-White syndrome with delta waves
seen best in leads I, II, and V3–V5, and a broad
QRS complex. This was confirmed by electrophy-
siologic study, during which a left lateral accessory
pathway with rapid antegrade conduction, down to
a cycle length of 170milliseconds, was successfully
catheter ablated (arrow).
At the age of 12 years, the patient experienced
the onset of headache, vomiting, impaired visual
acuity, and recurrent focal seizures. Blood and cere-
brospinal fluid lactate were increased at 5.6millimoles
per litres with a reference unit of 1.0–2.6millimoles
per litres and 3.7millimoles per litres with a reference
unit of 0.9–2.2millimoles per litres, respectively.
Electroencephalogram showed epileptic discharges on
the left occipital region, while magnetic resonance
imaging of the brain revealed localised T2-hyper-
intensity of the left occipital cortex and cerebellar
atrophy. The echocardiogram (Fig 2) in the parasternal
long (a) and short (b) axis views demonstrated, for the
first time, concentric left ventricular hypertrophy
(arrows). The left ventricular posterior wall measured
11 millimetres – the upper limit of normal was 8
millimetres – and the ventricular function was normal,
without outflow obstruction. MELAS syndrome
(mitochondrial myopathy, encephalopathy, lactic
acidosis, and stroke-like episodes) was suspected, and
the diagnostic A3243G mutation in mitochondrial
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tRNA was identified with a mutation load of 57% in
blood lymphocytes.
MELAS syndrome is known to be associated with
both hypertrophic cardiomyopathy and conductions
abnormalities, presumably as the consequence of
impairment of oxidative phosphorylation in tissues
with high energy demands.1 Wolff-Parkinson-White
Syndrome occurs at least four times more frequently in
patients with MELAS syndrome than in the normal
population that is, 13% versus 1.5 to 3.1%. Moreover,
as illustrated by our case, cardiac arrhythmias may
precede neurological manifestations by many months
or years, and patients who experience conduction
abnormalities may have an earlier onset of neurological
symptoms. In patients with Wolff-Parkinson-White
Syndrome and neurological symptoms, the presence of
a MELAS syndrome should be considered.
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